Home
About
Publications Trends
Recent Publications
Expert Search
Archive
biological markers
How Are Biomarkers Identified?
Identifying biomarkers involves understanding the
molecular and cellular processes
underlying cancer. Techniques such as
genomics
,
proteomics
, and
metabolomics
are employed to analyze genes, proteins, and metabolites in cancer cells.
Frequently asked queries:
What are Biological Markers?
How Are Biomarkers Identified?
Why Are Biomarkers Important?
How does NGS Work?
How Are Oncolytic Viruses Being Used?
Why Might Cancer Patients Need Hearing Aids?
How is Silica Exposure Linked to Cancer?
What is Microdialysis?
What is Manipulation in the Context of Cancer?
What are the Key Components of Global Cancer Standards?
What is 3D Cell Culture?
What Is the Future Direction?
Can Clonal Evolution be Targeted Therapeutically?
What Types of Impairment Are Common in Cancer Patients?
How do genetic mutations cause cancer?
What are the Common Causes of MNAR in Cancer Studies?
How Does Cloud Computing Benefit Cancer Research?
How have advancements in treatment technologies enhanced cancer treatment outcomes?
What is the Role of Diagnostics in Cancer Management?
How Can These Therapies Help Cancer Patients?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe